| T number | T00718 |
| Org_code | sml |
| Name | Stenotrophomonas maltophilia K279a |
| Annotation | yes |
| Taxonomy | TAX: 522373 |
| Lineage | Bacteria; Pseudomonadota; Gammaproteobacteria; Xanthomonadales; Xanthomonadaceae; Stenotrophomonas; Stenotrophomonas maltophilia group |
| Brite | KEGG organisms [BR:br08601]
KEGG organisms in the NCBI taxonomy [BR:br08610]
KEGG organisms in taxonomic ranks [BR:br08611] |
| Data source | GenBank (Assembly: GCA_000072485.1 Complete Genome)
BioProject: 30351 |
| Original DB | Sanger |
| Keywords | Human pathogen |
| Disease | H01069 Stenotrophomonas maltophilia infection |
| Comment | Isolated from a typical presentation: an elderly male patient undergoing chemotherapy at the Bristol Oncology Unit, Bristol, UK in 1998 developed a bloodstream infection that did not respond to therapy with piperacillin/tazobactam, ceftazidime or imipenem.
|
| Chromosome | Circular |
| Sequence | GB: AM743169 |
| Length | 4851126 |
| Statistics | Number of nucleotides: 4851126
Number of protein genes: 4386
|
| Created | 2008 |
| Reference | PMID: 18419807 |
| Authors | Crossman LC, Gould VC, Dow JM, Vernikos GS, Okazaki A, Sebaihia M, Saunders D, Arrowsmith C, Carver T, Peters N, et al. |
| Title | The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. |
| Journal | Genome Biol 9:R74 (2008)
DOI: 10.1186/gb-2008-9-4-r74 |
Stenotrophomonas maltophilia K279a